Inhibition of EMMPRIN by microRNA‑124 suppresses the growth, invasion and tumorigenicity of gliomas

Song,Yanbin; Bai,Lei; Yan,Feiping; Chen,Chen

doi:10.3892/etm.2021.10362

Inhibition of EMMPRIN by microRNA‑124 suppresses the growth, invasion and tumorigenicity of gliomas

Authors:
- Yanbin Song
- Lei Bai
- Feiping Yan
- Chen Chen
View Affiliations

Affiliations: Department of Neurosurgery, The First Hospital of Yulin, Yulin, Shanxi 719000, P.R. China
Published online on: July 1, 2021 https://doi.org/10.3892/etm.2021.10362
Article Number: 930
Copyright: © Song et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miR) are a group of non‑coding, small RNAs, 18‑20 nucleotides in length, that are frequently involved in the development of a variety of different types of cancer, including glioma, which is a type of severe tumor in the brain. Previous studies reported that miR‑124 levels were downregulated in glioma specimens; however, the potential role of miR‑124 in glioma currently remains unclear. The present study performed experiments, including dual‑luciferase reporter assay (DLRA), MTT assay, transwell assay and flow cytometry, with the aim of elucidating the molecular mechanism of miR‑124 in glioma. The results indicated that miR‑124 expression was decreased in glioma tissues, accompanied by the increased expression of extracellular matrix metalloproteinase inducer (EMMPRIN). The expression of EMMPRIN was inhibited by miR‑124 transfection. The DLRA results revealed that EMMPRIN directly targets miR‑124. Furthermore, upon overexpression of miR‑124 in the U87 cells, cell proliferation was significantly inhibited, apoptosis was increased, and cell migration and invasion were decreased. Furthermore, tumor growth was blocked by miR‑124 in mice. Based on these results, the present study concluded that miR‑124 is critical for amelioration of glioma by targeting EMMPRIN, thereby acting as a tumor suppressor. Thus, miR‑124/EMMPRIN constitutes a plausible basis for the treatment of glioma.

View Figures

View References

1	Jansson M, von Heymann-Horan AB, Rasmussen BK, Albieri V, Frederiksen K, Suppli N, Dalton SO, Johansen C and Bidstrup PE: Risk for use of antidepressants, anxiolytics, and hypnotics in partners of glioma patients-A nationwide study covering 19 years of prescriptions. Psychooncology. 27:1930–1936. 2018.PubMed/NCBI View Article : Google Scholar
2	Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, et al: The epidemiology of glioma in adults: A ‘state of the science’ review. Neuro Oncol. 16:896–913. 2014.PubMed/NCBI View Article : Google Scholar
3	Affronti ML, Jackman JG, McSherry F, Herndon JE II, Massey EC Jr, Lipp E, Desjardins A, Friedman HS, Vlahovic G and Peters KB: Phase II study to evaluate the efficacy and safety of rilotumumab and bevacizumab in subjects with recurrent malignant glioma. Oncologist. 23:889–e98. 2018.PubMed/NCBI View Article : Google Scholar
4	Ravn MB, Jakola AS, Reinertsen I, Sagberg LM, Unsgard G and Solheim O: The diagnostic properties of intraoperative ultrasound in glioma surgery and factors associated with gross total tumor resection. World Neurosurg. 115:e129–e136. 2018.PubMed/NCBI View Article : Google Scholar
5	Parente A, van Waarde A, Shoji A, de Paula FD, Maas B, Zijlma R, Dierckx R, Langendijk JA, de Vries EFJ and Doorduin J: PET imaging with S-[¹¹ C]Methyl-L-cysteine and L-[Methyl-¹¹ C]Methionine in rat models of glioma, glioma radiotherapy, and neuroinflammation. Mol Imaging Biol. 20:465–472. 2018.PubMed/NCBI View Article : Google Scholar
6	Fang Y, Jiang Y, Zou Y, Meng F, Zhang J, Deng C, Sun H and Zhong Z: Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. Acta Biomater. 50:396–406. 2017.PubMed/NCBI View Article : Google Scholar
7	Dai X, Ma C, Lan Q and Xu T: 3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility. Biofabrication. 8(45005)2016.PubMed/NCBI View Article : Google Scholar
8	Griveau A, Seano G, Shelton SJ, Kupp R, Jahangiri A, Obernier K, Krishnan S, Lindberg OR, Yuen TJ, et al: A glial signature and Wnt7 signaling regulate glioma-vascular interactions and tumor microenvironment. Cancer Cell. 33:874–889.e7. 2018.PubMed/NCBI View Article : Google Scholar
9	Ruan H, Chai Z, Shen Q, Chen X, Su B, Xie C, Zhan C, Yao S, Wang H, Zhang M, et al: A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery. J Control Release. 279:306–315. 2018.PubMed/NCBI View Article : Google Scholar
10	Khan MB, Schneider JR, Kwan K and Boockvar JA: Epigentic regulators of glioma stem cells are potential therapeutic targets. Neurosurgery. 82:E104–E105. 2018.PubMed/NCBI View Article : Google Scholar
11	Kim H, Yi SS, Lee HK, Heo TH, Park SK, Jun HS, Song KD and Kim SJ: Antiproliferative effect of vine stem extract from spatholobus suberectus Dunn on Rat C6 glioma cells through regulation of ROS, mitochondrial depolarization, and P21 protein expression. Nutr Cancer. 70:605–619. 2018.PubMed/NCBI View Article : Google Scholar
12	Nan Y, Guo H, Guo LY, Wang L, Ren BC, Yu K, Huang Q and Zhong Y: miRNA-451 inhibits glioma cell proliferation and invasion through the mTOR/HIF-1alpha/VEGF signaling pathway by targeting CAB39. Hum Gene Ther Clin Dev. 29:156–166. 2018.PubMed/NCBI View Article : Google Scholar
13	Lu F, Ye Y, Zhang H, He X, Sun X, Yao C, Mao H, He X, Qian C, Wang B, et al: miR-497/Wnt3a/c-jun feedback loop regulates growth and epithelial-to-mesenchymal transition phenotype in glioma cells. Int J Biol Macromol. 120:985–991. 2018.PubMed/NCBI View Article : Google Scholar
14	Chai C, Song LJ, Han SY, Li XQ and Li M: MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway. CNS Neurosci Ther. 24:369–380. 2018.PubMed/NCBI View Article : Google Scholar
15	Hui W, Yuntao L, Lun L, WenSheng L, ChaoFeng L, HaiYong H and Yueyang B: MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. PLoS One. 8(e54932)2013.PubMed/NCBI View Article : Google Scholar
16	Yan D, Hao C, Xiao-Feng L, Yu-Chen L, Yu-Bin F and Lei Z: Molecular mechanism of Notch signaling with special emphasis on microRNAs: Implications for glioma. J Cell Physiol. 234:158–170. 2018.PubMed/NCBI View Article : Google Scholar
17	Gu G, Wang L, Zhang J, Wang H, Tan T and Zhang G: MicroRNA-384 inhibits proliferation migration and invasion of glioma by targeting at CDC42. Onco Targets Ther. 11:4075–4085. 2018.PubMed/NCBI View Article : Google Scholar
18	Wu Q, Xu L, Wang C, Fan W, Yan H and Li Q: MicroRNA-124-3p represses cell growth and cell motility by targeting EphA2 in glioma. Biochem Biophys Res Commun. 503:2436–2442. 2018.PubMed/NCBI View Article : Google Scholar
19	von Ungern-Sternberg SNI, Zernecke A and Seizer P: Extracellular matrix metalloproteinase inducer EMMPRIN (CD147) in cardiovascular disease. Int J Mol Sci. 19(507)2018.PubMed/NCBI View Article : Google Scholar
20	Horikawa Y, Watanabe M, Sadahira T, Ariyoshi Y, Kobayashi Y, Araki M, Wada K, Ochiai K, Li SA and Nasu Y: Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells. Oncol Lett. 14:3223–3228. 2017.PubMed/NCBI View Article : Google Scholar
21	Zhou Y, Di Z, Li X, Shan Y, Li W, Zhang H and Xiao Y: Chemical proteomics reveal CD147 as a functional target of Pseudolaric acid B in human cancer cells. Chem Commun (Camb). 53:8671–8674. 2017.PubMed/NCBI View Article : Google Scholar
22	Jia L, Zhou H, Wang S, Cao J, Wei W and Zhang J: Deglycosylation of CD147 down-regulates Matrix Metalloproteinase-11 expression and the adhesive capability of murine hepatocarcinoma cell HcaF in vitro. IUBMB Life. 58:209–216. 2006.PubMed/NCBI View Article : Google Scholar
23	Zhang Z, Zhao Y, Jiang L, Miao X, Zhou H and Jia L: Glycomic alterations are associated with multidrug resistance in human leukemia. Int J Biochem Cell Biol. 44:1244–1253. 2012.PubMed/NCBI View Article : Google Scholar
24	Arora M and Mane DR: Immunohistochemical expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma. J Oral Maxillofac Pathol. 22:279–280. 2018.PubMed/NCBI View Article : Google Scholar
25	Zheng HC and Gong BC: CD147 expression was positively linked to aggressiveness and worse prognosis of gastric cancer: A meta and bioinformatics analysis. Oncotarget. 8:90358–90370. 2017.PubMed/NCBI View Article : Google Scholar
26	Yin H, Shao Y and Chen X: The effects of CD147 on the cell proliferation, apoptosis, invasion, and angiogenesis in glioma. Neurol Sci. 38:129–136. 2017.PubMed/NCBI View Article : Google Scholar
27	Li H, Xi Z, Dai X, Wu W, Li Y, Liu Y and Zhang H: CD147 and glioma: A meta-analysis. J Neurooncol. 134:145–156. 2017.PubMed/NCBI View Article : Google Scholar
28	Wijnenga M, French PJ, Dubbink HJ, Dinjens W, Atmodimedjo PN, Kros JM, Fleischeuer R, Dirven C, Vincent A and van den Bent MJ: Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma. J Neurooncol. 139:349–357. 2018.PubMed/NCBI View Article : Google Scholar
29	Andronesi OC, Arrillaga-Romany IC, Ly KI, Bogner W, Ratai EM, Reitz K, Iafrate AJ, Dietrich J, Gerstner ER, Chi AS, et al: Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate. Nat Commun. 9(1474)2018.PubMed/NCBI View Article : Google Scholar
30	Subburayan K, Thayyullathil F, Pallichankandy S, Rahman A and Galadari S: Par-4-dependent p53 up-regulation plays a critical role in thymoquinone-induced cellular senescence in human malignant glioma cells. Cancer Lett. 426:80–97. 2018.PubMed/NCBI View Article : Google Scholar
31	Liu SJ, Yang TC, Yang ST, Chen YC and Tseng YY: Biodegradable hybrid-structured nanofibrous membrane supported chemoprotective gene therapy enhances chemotherapy tolerance and efficacy in malignant glioma rats. Artif Cells Nanomed Biotechnol. 46 (Suppl 2):S515–S526. 2018.PubMed/NCBI View Article : Google Scholar
32	Chen X, Li D, Gao Y, Cao Y and Hao B: Histone deacetylase SIRT6 inhibits glioma cell growth through down-regulating NOTCH3 expression. Acta Biochim Biophys Sin (Shanghai). 50:417–424. 2018.PubMed/NCBI View Article : Google Scholar
33	Lee YS and Dutta A: MicroRNAs in cancer. Annu Rev Pathol. 4:199–227. 2009.PubMed/NCBI View Article : Google Scholar
34	Cortez MA, Anfossi S, Ramapriyan R, Menon H, Atalar SC, Aliru M, Welsh J and Calin GA: Role of miRNAs in immune responses and immunotherapy in cancer. Genes Chromosomes Cancer. 58:244–253. 2019.PubMed/NCBI View Article : Google Scholar
35	Hu C, Dong X, Wu J, Xiao F, Shang J, Liu L, Yang Y, Luo D, Li Q, Song Q, et al: CD147 overexpression may serve as a promising diagnostic and prognostic marker for gastric cancer: Evidence from original research and literature. Oncotarget. 8:30888–30899. 2017.PubMed/NCBI View Article : Google Scholar
36	Zhang X, Tian T, Zhang X, Liu C and Fang X: Elevated CD147 expression is associated with shorter overall survival in non-small cell lung cancer. Oncotarget. 8:37673–37680. 2017.PubMed/NCBI View Article : Google Scholar
37	Fei F, Li S, Fei Z and Chen Z: The roles of CD147 in the progression of gliomas. Expert Rev Anticancer Ther. 15:1351–1359. 2015.PubMed/NCBI View Article : Google Scholar
38	Sameshima T, Nabeshima K, Toole BP, Yokogami K, Okada Y, Goya T, Koono M and Wakisaka S: Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int J Cancer. 88:21–27. 2000.PubMed/NCBI View Article : Google Scholar
39	Hu Z, Cai M, Deng L, Zhu L, Gao J, Tan M, Liu J and Lin B: The fucosylated CD147 enhances the autophagy in epithelial ovarian cancer cells. Oncotarget. 7:82921–82932. 2016.PubMed/NCBI View Article : Google Scholar
40	Kendrick AA, Schafer J, Dzieciatkowska M, Nemkov T, D'Alessandro A, Neelakantan D, Ford HL, Pearson CG, Weekes CD, Hansen KC and Eisenmesser EZ: CD147: A small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming. Oncotarget. 8:6742–6762. 2017.PubMed/NCBI View Article : Google Scholar
41	Martins SF, Amorim R, Viana-Pereira M, Pinheiro C, Costa RF, Silva P, Couto C, Alves S, Fernandes S, Vilaca S, et al: Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis. BMC Cancer. 16(535)2016.PubMed/NCBI View Article : Google Scholar
42	Ju X, Liang S, Zhu J, Ke G, Wen H and Wu X: Extracellular matrix metalloproteinase inducer (CD147/BSG/EMMPRIN)-induced radioresistance in cervical cancer by regulating the percentage of the cells in the G2/m phase of the cell cycle and the repair of DNA double-strand breaks (DSBs). Am J Transl Res. 8:2498–2511. 2016.PubMed/NCBI